# PHASE Scientific International

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/phase-scientific-international

- Industry: Biotechnology
- Headquarters: Hong Kong, Hong Kong SAR - China
- Website: www.phasescientific.com/
- Total disclosed funding: $34M
- Latest round: Series A (May 19, 2025)
- Investors on record: 1

## About

Based in Hong Kong, PHASE Scientific is a biotech company focused on developing innovative diagnostic solutions that empower individuals to manage their health effectively through reliable testing options.Founded in 2015, PHASE Scientific specializes in health-focused diagnostic solutions. The company is headquartered in Hong Kong and has established itself with a singular focus on health diagnostics since its inception. Recent funding activities include a Series A round in May 2025 where the company raised USD 34.00 mn led by Value Partners, marking a significant financial milestone for further growth initiatives.PHASE Scientific Americas offers innovative diagnostic solutions prioritizing accessible health management. Their key products include the INDICAID health platform, featuring at-home collection kits for diabetes and heart health, and INDICAID rapid antigen tests for infectious diseases. These offerings enhance user convenience and are distributed across North America and other international markets, targeting both consumers and healthcare providers.PHASE Scientific Americas generates revenue through direct-to-consumer and business-to-business channels, including partnerships with healthcare providers. Clients acquire INDICAID products through retail and online avenues, fostering a diverse revenue stream. The company's flagship products, including rapid antigen tests and at-home collection kits, are central to its sales strategy, aiming to capture significant market share in health diagnostics.In May 2025, PHASE Scientific International Limited raised USD 34.00 mn in Series A funding, spearheaded by Value Partners, with plans to utilize these funds for product research, development, and commercialization. The company is focusing on expanding its product line and is preparing to enter new geographic markets, although specific regions have not yet been disclosed.

## Funding rounds

- Series A, May 19, 2025, $34M — Value Partners Group

## Investors

- Value Partners Group (https://capitalatlas.ai/funds/value-partners-group) — Series A